APOA4 anticorps (C-Term)
-
- Antigène Voir toutes APOA4 Anticorps
- APOA4 (Apolipoprotein A-IV (APOA4))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp APOA4 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- RQKLGPHAGD VEGHLSFLEK DLRDKVNSFF STFKEKESQD KTLSLPELEQ
- Homologie
- Human: 100%
- Attributs du produit
- This is a rabbit polyclonal antibody against APOA4. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the C terminal region of human APOA4
- Top Product
- Discover our top product APOA4 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 396 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background." dans: BMC bioinformatics, Vol. 9, pp. 254, (2008) (PubMed).
: "
-
New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background." dans: BMC bioinformatics, Vol. 9, pp. 254, (2008) (PubMed).
-
- Antigène
- APOA4 (Apolipoprotein A-IV (APOA4))
- Autre désignation
- APOA4 (APOA4 Produits)
- Synonymes
- anticorps Apo-AIV, anticorps ApoA-IV, anticorps apoAIV, anticorps APOAIV, anticorps APOA4, anticorps myh11, anticorps Apoa-4, anticorps apolipoprotein A4, anticorps apolipoprotein A4 L homeolog, anticorps apolipoprotein A-IV, anticorps apolipoprotein A-IV a, anticorps APOA4, anticorps Apoa4, anticorps apoa4, anticorps apoa4.L, anticorps apoa4a
- Sujet
-
The gene encoding APOA4 protein contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro.Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: MGC142154, MGC142156
Protein Interaction Partner: ALB, GPLD1, APOA4,
Protein Size: 396 - Poids moléculaire
- 43 kDa
- ID gène
- 337
- NCBI Accession
- NM_000482, NP_000473
- UniProt
- P06727
- Pathways
- Lipid Metabolism
-